SAN FRANCISCO, March 9, 2021-- Claritas Rx, the leading provider of data and analytics solutions covering specialty and rare disease patients, today announced the closing of a significant growth equity investment from Questa Capital, a venture growth equity firm focused on investing in expansion-stage healthcare companies. The funds will be used to enhance drug and patient analytics with innovative new products, accelerate sales & marketing, and expand the company's management team. In today's complex specialty pharmaceutical networks, manufacturers must integrate channel, commercial and clinical data at scale to understand the real-world patient journey.